Comparative studies of quality and bioavailability of methotrexate in Thai patients with rheumatoid arthritis

Journal of the Medical Association of Thailand

Volumn 81, Issue 12, 1998, Pages 977-985

  Manorot, Maleeya ^a   Louthrenoo, Worawit ^a   Teekachunhatean, Supanimit ^a   Rojanasathien, Noppamas ^a   Tonsuwannont, Wittaya ^b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; ARTICLE; BIOEQUIVALENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED;

EID: 0032429324     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Physician Desk Reference. Medical Economics, Montvale, NJ., 51th ed., 1997: 1322-7.
2. Bannwarth B, Labat L, MorideY, Schaeverbeke T. Methotrexate in rheumatoid arthritis. An update. Drugs 1994; 47: 25-50.
3. Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN. Efficacy of low dose methotrexate in rheumatoid arthritis. N Engl J Med 1985; 312: 818-22.
4. Salach RH, Cash JM. Methotrexate : the emerging drug of choice for serious rheumatoid arthritis. Clin Ther 1994; 16: 912-22.
5. Felson DT, Anderson JJ, Meenan RF. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis : results of two meta-analyses. Arthritis Rheum 1990; 33: 1449-61.
6. Jundt JW, Browne BA, Fiocco GP, Steele AD, Mock D. A comparison of low dose methotrexate bioavailability : oral solution, oral tablet, subcutaneous and intramuscular dosing. J Rheumatol 1993; 20: 1845-9.
7. Herman RA, Veng-Pederson P, Hoffman J, Koehnke R, Furst DE. Pharmacokinetic of low-dose methotrexate in rheumatoid arthritis patients. J Pharmacol Sci 1989; 78: 165-71.
8. Bannwarth B, Pehourcq F, Schaeverbeke T, Dehais J. Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis. Clin Pharmacokinet 1996; 30: 194-210.
9. Nation LR, Sansom NL. Bioequivalence requirements for generic products. Pharmacol Ther 1994; 62: 42-55.
10. US Department of Health and Human Services Food and Drug Administration. Approved drug products with therapeutic equivalence evaluation. 11 th ed. Bethesda (MD) : US Government Printing Office, 1991.
11. Pesce MA, Bodourian DH. Evaluation of fluorescence polarization immunoassay procedure for quantitation of methotrexate. Trier Drug Monit 1986; 8: 115-21.
12. Sauter R, Steinijans VW, Diletti E, Bohm A, Schultz HU. Presentation of results from bioequivalence studies. Int J Clin Pharmacol Ther Toxicol 1992; 30(Suppl. 1): S7-30.
13. Lebbe C, Beyeler C, Gerber NJ, Reichen J. Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis. Ann Rheum Dis 1994; 53: 475-7.
14. Kremer JM, Hamilton RA. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg. J Rheumatol 1995; 22: 2072-7.
15. Gumbhir Shah K, Cevallos WH, DeCleene SA, Korth Bradley JM. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis. J Rheumatol 1996; 23: 984-9.
16. Dupis LL, Koren G, Shore A, Silverman ED, Laxer RM. Methotrexate-nonsteroidal anti-inflammatory drug interaction in children with arthritis. J Rheumatol 1990; 17: 1469-73.
17. Shen DD, Azarnoff DL. Clinical pharmacokinetics of methotrexate. Clin Pharmacokinet 1978; 3: 1-13.
18. Skeith KJ, Russell AS, Jamali F, Coates J, Friedman H. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis. J Rheumatol 1990; 17: 1008-10.
19. Stewart CF, Fleming RA, Germain BF, Seleznick MJ, Evans WE. Aspirin alters methotrexate disposition in rheumatoid arthritis patients. Arthritis Rheum 1991; 34: 1514-20.